Comparative Efficacy and Speed of Onset of Action of Infliximab vs Golimumab in Ulcerative Colitis

Authors:

Abstract
No abstract available
Funding Information
  • Gilead Sciences
  • Tillotts Pharma
  • Teva Pharmaceutical Industries
  • Atlantic Healthcare
  • AbbVie
  • Takeda Pharmaceuticals U.S.A.
  • Shire
  • Merck
  • Ferring Pharmaceuticals
  • Bristol-Myers Squibb
  • Crohn's and Colitis Foundation (404614, UL1TR001442)
  • Pfizer
  • Seres Therapeutics
  • GlaxoSmithKline
  • Novo Nordisk
  • Johnson and Johnson
  • American College of Gastroenterology
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Janssen Pharmaceutica
  • National Institutes of Health (K23DK117058)

This publication has 27 references indexed in Scilit: